Uncategorized
Within the early days of the pandemic, throughout a free stay occasion, I suggested readers to start out inserting bets on “first-order” alternatives.
These alternatives have been in testing and vaccine firms, as demand in these areas could be the primary issues to skyrocket as traders woke as much as the severity of the pandemic.
It labored out, too:
A number of firms that I singled out — like vaccine front-runner Moderna, Inc. (MRNA) and take a look at maker Quidel Company (QDEL) — rapidly soared in value. As a lot as 557% in Moderna’s case.
However fast-forward to at the moment, and never solely is testing widespread, however the first doses of Covid-19 vaccines are actually being administered.
In different phrases, the primary a part of the development is totally realized. And which means it’s time to start out investing in second-order alternatives.
These are firms that benefit from the subsequent section of any development’s progress.
And within the case of Covid-19, I firmly imagine such alternatives exist in applied sciences that guarantee we are able to safely congregate in public areas once more.
And that’s the place Kontrol Vitality Corp. (KNRLF) is available in…
Necessity is the Mom of All
Based in 2015, Kontrol is a Canadian firm that operates within the sensible metropolis/constructing and IoT markets.
Extra particularly, the corporate gives a mixture of software program, {hardware}, and repair options to prospects to enhance power administration, air high quality, and emissions monitoring.
In case you didn’t know, it is a large market alternative. Living proof: North American buildings waste as much as $60 billion in power yearly, which additionally accounts for pointless greenhouse fuel emissions.
Like many companies, Kontrol encountered new challenges sustaining regular operations because the pandemic worsened.
It couldn’t get entry to its prospects’ buildings, which is when the lightbulb went off.
Administration realized the know-how it already owned for air high quality and emissions monitoring may very well be leveraged to create a completely new tech resolution with broader enchantment — and extra pressing enchantment.
Introducing BioCloud
Kontrol’s newly developed BioCloud is a real-time analyzer designed to detect airborne pathogens, together with SARS-COV-2.
Consider it like a smoke detector or carbon monoxide detector, just for airborne viruses, micro organism, and fungi.
It really works by repeatedly sampling air high quality and triggering a silent, cloud-based alert to constructing managers. Every unit can cowl as much as 750 sq. toes.
Right here’s the important thing…
This isn’t some idea or pipedream. It’s an actual product that’s able to ship, which is a formidable feat.
Administration solely developed the idea in March. However then it kicked into hyperdrive, given the pressing market want.
- In June, the primary prototype was developed.
- In July, the corporate secured authorities funding to speed up improvement.
- And in August and September, impartial third-party testing was accomplished, verifying the operation of the know-how — and most significantly, verifying its potential to detect Covid-19.
In current months, the corporate secured one other $500,000 in federal grants, ramped up manufacturing capability, inked distribution agreements, and filed key patents to guard the know-how.
And originally of this week, the corporate introduced that it’s set to ship the primary items to prospects world wide.
I wouldn’t be shocked to see further press releases within the coming weeks asserting preliminary gross sales…
Particularly since every unit is anticipated to price simply $12,000.
For a corporation like a fast-food restaurant, $12,000 could be a tiny value to pay so its prospects might really feel safe understanding the situation is protected and free from Covid-19.
With roughly 250,000 fast-food eating places within the U.S. alone, you can begin to grasp the market and revenue alternative right here for the $89 million market cap Kontrol.
Add in faculties, break rooms at places of work, gyms, and many others., and the listing of potential installations goes on and on.
Future Proof
However what I like most about this know-how is that it is future proof.
By that I imply, it’s not only for detecting Covid-19. No matter airborne pathogen threatens our lifestyle sooner or later, BioCloud might be tailored to start out detecting it, too.
Add all of it up — and identical to testing and vaccine firms in March, BioCloud is the precise alternative on the proper time… proper now.
Relaxation assured, I’m on the hunt for different equally compelling second-order alternatives.
Within the interim, you’d be clever to contemplate including just a few shares of Kontrol Vitality Corp. (KNRLF) to your portfolio at the moment.
On the very least, I encourage you to hearken to the corporate’s presentation for analysts and traders about its new product, scheduled for subsequent week (particulars right here).
I’ll definitely be tuning in and reporting again with any key takeaways.
Forward of the tape,
Lou Basenese